International Assets Investment Management LLC Has $152,000 Stock Position in Oncolytics Biotech Inc. (NASDAQ:ONCY)

International Assets Investment Management LLC cut its holdings in shares of Oncolytics Biotech Inc. (NASDAQ:ONCY) by 12.1% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 174,331 shares of the company’s stock after selling 24,069 shares during the period. International Assets Investment Management LLC’s holdings in Oncolytics Biotech were worth $152,000 as of its most recent filing with the Securities and Exchange Commission.

Separately, Virtu Financial LLC bought a new position in shares of Oncolytics Biotech in the 1st quarter worth $55,000. 6.82% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright reiterated a “buy” rating and issued a $5.00 price objective on shares of Oncolytics Biotech in a report on Thursday, September 19th.

Oncolytics Biotech Stock Performance

Shares of NASDAQ ONCY opened at $1.07 on Friday. Oncolytics Biotech Inc. has a 52-week low of $0.84 and a 52-week high of $1.75. The stock has a market cap of $82.46 million, a P/E ratio of -3.82 and a beta of 1.69. The firm has a 50 day moving average price of $1.08 and a 200 day moving average price of $1.06.

Oncolytics Biotech Profile

Oncolytics Biotech Inc, a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma.